Compare · OFLX vs ZBH
OFLX vs ZBH
Side-by-side comparison of Omega Flex Inc. (OFLX) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- OFLX operates in Industrials, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $17.67B, about 51.0x OFLX ($346.3M).
- Over the past year, OFLX is up 8.9% and ZBH is down 10.2% - OFLX leads by 19.1 points.
- ZBH has hit the wire 2 times in the past 4 weeks while OFLX has been quiet.
- ZBH has more recent analyst coverage (25 ratings vs 0 for OFLX).
- Company
- Omega Flex Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $33.93+1.47%
- $91.33-1.18%
- Market cap
- $346.3M
- $17.67B
- 1M return
- +12.99%
- +4.25%
- 1Y return
- +8.87%
- -10.23%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 25
Omega Flex Inc.
Omega Flex, Inc., together with its subsidiaries, manufactures and sells flexible metal hoses and accessories in the United States and internationally. It offers flexible gas piping for use in residential and commercial buildings, as well as its fittings; and corrugated medical tubing for use in hospitals, ambulatory care centers, dental, physician and veterinary clinics, laboratories, and other facilities. The company sells its products under the TracPipe, CounterStrike, AutoSnap, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac brand names. It serves various markets, including construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. The company sells its products through independent sales representatives, distributors, original equipment manufacturers, and direct sales, as well as through its website. The company was formerly known as Tofle America, Inc. and changed its name to Omega Flex, Inc. in 1996. Omega Flex, Inc. was incorporated in 1975 and is based in Exton, Pennsylvania.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest OFLX
- Omega Flex, Inc. Announces Regular Quarterly Dividend for the First Quarter 2026
- Omega Flex Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Chief Executive Officer Rivest Dean W. bought $29,500 worth of shares (1,000 units at $29.50) (SEC Form 4)
- SEC Form 10-K filed by Omega Flex Inc.
- Omega Flex, Inc. Announces Fourth Quarter 2025 Earnings
- Omega Flex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Vice President - CFO Unger Matthew Francis converted options into 395 shares and returned $14,832 worth of shares to the company (395 units at $37.55) (SEC Form 4)
- President Moran Edwin B. returned $18,550 worth of shares to the company (494 units at $37.55) and converted options into 494 shares (SEC Form 4)
- Chief Executive Officer Rivest Dean W. converted options into 593 shares and returned $22,267 worth of shares to the company (593 units at $37.55) (SEC Form 4)
- SEC Form 4 filed by VP, General Counsel, Secretary Asch Susan B.
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert